Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. COSM
stocks logo

COSM

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2024Q4
FY2025Q1
14.50M
-8.46%
--
--
15.50M
+6.28%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Cosmos Health Inc. (COSM) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -23.57%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-23.57%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Cosmos Health Inc (COSM.O) is 49.60, compared to its 5-year average forward P/E of 7.21. For a more detailed relative valuation and DCF analysis to assess Cosmos Health Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
7.21
Current PE
49.60
Overvalued PE
32.51
Undervalued PE
-18.09

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.60
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
7.74
Undervalued EV/EBITDA
-10.93

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.21
Current PS
0.00
Overvalued PS
0.46
Undervalued PS
-0.04
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

COSM News & Events

Events Timeline

(ET)
2025-12-03
12:30:00
Cosmos Health Announces Strategic Partnership with Prime Ledger
select
2025-11-17 (ET)
2025-11-17
09:19:24
Cosmos Health announces Q3 adjusted earnings per share of 2 cents, compared to a loss of 34 cents in the previous year.
select
2025-10-31 (ET)
2025-10-31
10:46:37
Cosmos Health Launches New Program for Nanotechnology Research and Development
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
12-04Newsfilter
Cosmos Health Partners with Prime Ledger to Manage $300M Treasury and Tokenize IP
  • Strategic Partnership: Cosmos Health has entered a long-term strategic partnership with Prime Ledger to digitally transform its financial operations, particularly managing a $300 million treasury, thereby enhancing efficiency and reducing risk in treasury management.
  • Asset Tokenization: A cornerstone of this collaboration is the tokenization of Cosmos Health's high-value intellectual property, with Prime Ledger designing a token issuance platform that will unlock new capitalization channels and drive innovation and growth.
  • Data Infrastructure Integration: The partnership also includes integrating Cosmos Health's data infrastructure using Prime Ledger's relationship with Conduit Network, which will optimize on-chain and off-chain data management, enhancing financial reporting and compliance capabilities.
  • Project Commencement: The initial phase of this engagement is set to begin in Q4 2025, focusing on strategic planning and platform design, marking a significant advancement for Cosmos Health in the digital economy.
[object Object]
Preview
5.0
12-03Newsfilter
Cosmos Health CEO Greg Siokas Acquires Over 3.3 Million Shares, Expresses Strong Confidence
  • Share Acquisition: Cosmos Health CEO Greg Siokas acquired 301,101 shares between November 19 and 28, 2025, increasing his total ownership to 6,459,985 shares, reflecting strong confidence in the company's future prospects.
  • Record Performance: The company reported record quarterly revenue, gross profit, and gross margins in Q3 2025, which influenced Siokas's decision to increase his holdings, indicating his belief in sustained growth.
  • Global Expansion: Cosmos Health is expanding its operations globally, particularly in Europe, Asia, and North America, and Siokas's share acquisition further demonstrates his support for the company's global strategy.
  • Innovative Product Pipeline: The company focuses on developing innovative solutions targeting major health issues such as obesity, diabetes, and cancer, and Siokas's increased ownership will help advance these initiatives.
[object Object]
Preview
5.0
12-03Globenewswire
Cosmos Health CEO Greg Siokas Acquires Over 3.39 Million Shares, Expresses Strong Confidence
  • Share Acquisition: Cosmos Health CEO Greg Siokas acquired 301,101 shares between November 19 and 28, 2025, increasing his total holdings to 6,459,985 shares, demonstrating strong confidence in the company's future prospects.
  • Record Performance: The company reported record-breaking Q3 2025 results with all-time-high quarterly revenue, gross profit, and gross margins, driven by robust growth across core business segments, and expects this momentum to continue into Q4, further solidifying its market position.
  • Global Expansion Plans: Siokas indicated that despite valuation pressures, he remains confident in Cosmos Health's potential for global expansion and innovative product pipelines, planning to continue supporting the company's strategic objectives.
  • Investor Confidence: Siokas's share acquisition not only reflects his optimistic outlook for the company’s future but may also enhance investor confidence in Cosmos Health, potentially leading to positive impacts on its stock price.
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Cosmos Health Inc (COSM) stock price today?

The current price of COSM is 0.496 USD — it has increased 1.02 % in the last trading day.

arrow icon

What is Cosmos Health Inc (COSM)'s business?

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.

arrow icon

What is the price predicton of COSM Stock?

Wall Street analysts forecast COSM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for COSM is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Cosmos Health Inc (COSM)'s revenue for the last quarter?

Cosmos Health Inc revenue for the last quarter amounts to 17.11M USD, increased 37.86 % YoY.

arrow icon

What is Cosmos Health Inc (COSM)'s earnings per share (EPS) for the last quarter?

Cosmos Health Inc. EPS for the last quarter amounts to -0.17 USD, decreased -62.22 % YoY.

arrow icon

What changes have occurred in the market's expectations for Cosmos Health Inc (COSM)'s fundamentals?

The market is revising No Change the revenue expectations for Cosmos Health Inc. (COSM) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -23.57%.
arrow icon

How many employees does Cosmos Health Inc (COSM). have?

Cosmos Health Inc (COSM) has 149 emplpoyees as of December 05 2025.

arrow icon

What is Cosmos Health Inc (COSM) market cap?

Today COSM has the market capitalization of 17.32M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free